We only have this paper's title and publication details.
Read it at the sourceAssesses PD-L1+ circulating stem cells as prognostic biomarkers for recurrence-free survival and overall survival in hepatocellular carcinoma patients, suggesting potential...
No takes yet. Share an insight, caveat, or question.
Roy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: